Drug recall · April 12, 2017
Ibuprofen Lysine Injection recall
Why: Presence of Particulate Matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.
- Lots / codes
PLND1613, Exp 02/18
- Quantity
- 2593 cartons
- Company
- X-Gen Pharmaceuticals Inc., Horseheads, NY
- Distribution
- Nationwide in the USA.
- Initiated
- February 8, 2017 · Voluntary: Firm initiated
- Classified
- April 5, 2017
- Reported
- April 12, 2017
- Ended
- June 10, 2020
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.